COMMUNIQUÉS West-GlobeNewswire

Breathtec Announces Closing of Private Placement

24/10/2018 - 13:00

Not for distribution to United States newswire services or for dissemination in the United States. VANCOUVER, British Columbia, Oct. 24, 2018 (GLOBE NEWSWIRE) -- Breathtec Biomedical Inc. (CSE: BTH ) (CNSX: BTH ) ( [...]

Evogene Financial Results for the Third Quarter of 2018 Earnings Announcement Schedule

24/10/2018 - 13:00

REHOVOT, Israel, Oct. 24, 2018 (GLOBE NEWSWIRE) -- Evogene Ltd. (NASDAQ, TASE: EVGN), a leading biotechnology company developing novel products for life science markets, announced today that it will release its [...]

miRagen Therapeutics to Report Third Quarter 2018 Financial Results and Host Conference Call on November 7, 2018

24/10/2018 - 13:00

BOULDER, Colo., Oct. 24, 2018 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, will host a [...]

Optos and Amydis Establish Clinical Alliance to Develop Early Diagnostic Test for Alzheimer’s Disease

24/10/2018 - 13:00

LOS ANGELES, Oct. 24, 2018 (GLOBE NEWSWIRE) -- Optos Plc, a subsidiary of Nikon Corporation, Japan, and Amydis, Inc. today announced a clinical alliance focused on the development of an eye test by Amydis to detect [...]

BeiGene Announces Acceptance of its New Drug Application in China and Top-Line Pivotal Data for Zanubrutinib in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

24/10/2018 - 13:00

BEIJING, China, and CAMBRIDGE, Mass., Oct. 24, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]

Sharps Compliance Reports Fiscal 2019 First Quarter Results

24/10/2018 - 12:55

First quarter 2019 revenue increased to $10.3 million with gross margin of 33%, net income of $0.1 million and break-even net income per share Unused Medication solutions business increased 40% Route-based business [...]

Tetra Bio-Pharma Appoints Richard Giguère Chief Executive Officer of Tetra Natural Health

24/10/2018 - 12:30

ORLEANS, Ontario, Oct. 24, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc ., a leader in cannabinoid-based drug discovery and development (TSX VENTURE: TBP) (OTCQB: TBPMF), today announced the appointment of Richard [...]

Natus Medical Announces Third Quarter Financial Results

24/10/2018 - 12:30

Reports record third quarter revenue of $130.6 million Reports third quarter GAAP loss per share of $0.17 and non-GAAP earnings per share of $0.40 Updates annual revenue and earnings guidance for 2018 PLEASANTON, Calif [...]

TRU NIAGEN® Daily Serving Strengthened Under FDA’s NDI Notification

24/10/2018 - 12:30

ChromaDex increases capsule serving to 150mg TRU NIAGEN ® (nicotinamide riboside), following successful New Dietary Ingredient (NDI) notification from FDA LOS ANGELES, Oct. 24, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. ( [...]

Emblem finalizes agreement to launch Emblem Germany in joint venture with Acnos Pharma

24/10/2018 - 12:30

Agreement will see Emblem export to one of the world’s largest legal medical cannabis markets TORONTO, Oct. 24, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX:EMMBF) ("Emblem" or the "Company"), today announced [...]

ViroGates releases third quarter 2018 results

24/10/2018 - 12:20

Company announcement no. 7-2018 Birkerød, 24 October 2018 ViroGates A/S (Nasdaq First North Denmark: VIRO), who delivers blood test systems for emergency departments in hospitals, today reported financial results for [...]

Mesoblast Expands Partnership With JCR Pharmaceuticals for Treatment of Wound Healing in Epidermolysis Bullosa

24/10/2018 - 12:05

NEW YORK and MELBOURNE, Australia, Oct. 24, 2018 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB; Nasdaq:MESO) today announced it has expanded its partnership with JCR Pharmaceuticals Co. Ltd. in Japan for wound healing [...]

Immunicum AB: Invitation to Investor Events in Gothenburg and Stockholm

24/10/2018 - 12:01

Press Release 24 October 2018 Immunicum AB: Invitation to Investor Events in Gothenburg and Stockholm Immunicum AB (publ; IMMU.ST) announced today that the Company will host two investor events in October. At both [...]

Orion and Amgen to collaborate on the commercialisation of AMGEVITA® (biosimilar adalimumab) in Finland

24/10/2018 - 11:31

Orion Corporation Press Release 24 October 2018 at 12.30 p.m. EEST Orion and Amgen to collaborate on the commercialisation of AMGEVITA ® (biosimilar adalimumab) in Finland Orion Corporation and Amgen have signed an [...]

Opthea To Present Update at the Ophthalmology Innovation Summit in Chicago

24/10/2018 - 11:30

MELBOURNE, Australia, Oct. 24, 2018 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT), a clinical-stage biopharmaceutical company developing novel biologic therapies to treat back-of-the-eye diseases, announced today that Dr [...]

Orion Group Interim Report January-September 2018

24/10/2018 - 11:01

ORION CORPORATION INTERIM REPORT JANUARY-SEPTEMBER 2018 24 OCTOBER 2018 at 12.00 EEST Orion Group Interim Report January-September 2018 Orion's net sales for continuing operations in January-September 2018 totalled EUR [...]

PCI Biotech: Capital increase registered and listing of new shares

24/10/2018 - 11:01

Oslo, Norway, 24 October 2018. Reference is made to the previous announcements by PCI Biotech Holding ASA ("PCI Biotech" or the "Company") in respect of the issuance of 170,000 new shares following exercise of employee [...]

EssilorLuxottica : Mise à disposition d'une note complémentaire au prospectus ayant reçu le visa n°18-460 de l'AMF le 28 septembre 2018

24/10/2018 - 08:01

Mise à disposition d'une note complémentaire au prospectus ayant reçu le visa n°18-460 de l'AMF le 28 septembre 2018 Version PDF du communiqué Charenton-le-Pont, France (24 octobre 2018 - 8h00) - EssilorLuxottica [...]

Rule 2.9 Announcement

24/10/2018 - 08:00

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 24 October 2018 [...]